New light scanner could replace liver biopsies for transplant patients
NCT ID NCT07254533
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a near-infrared spectroscopy device that scans the liver with light to diagnose and measure fatty liver disease. Researchers aim to see if it can accurately detect fat levels above 5% and 30%, which are important for liver transplant decisions. The study will include 90 liver grafts and surgical samples from adults. If it works, this non-invasive tool could replace the current biopsy method, which is invasive and can vary between doctors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
near-infrared spectrometer
What this could lead to
If successful, this could provide a quick, non-invasive way to measure liver fat, helping doctors decide which donor livers are safe to transplant.
What could go wrong
This is an early-stage study with only 90 participants, and the device may not be accurate enough to replace current biopsy methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Timone Hospital
Marseille, 13005, France
Contact Phone: •••-•••-•••• Email: •••••@•••••